Daniel S. Goldman sold Halozyme Therapeutics Inc (NASDAQ: HALO)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Halozyme Therapeutics Inc (HALO) since 2023, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $15,001 - $50,000 of Halozyme Therapeutics Inc (NASDAQ: HALO) on July 12, 2023. Since that trade, HALO is up +123.98% against the S&P 500 up +72.17%, an outperformance of +51.82%.
Data updated
Daniel S. Goldman's HALO trades vs the price
HALO is up +123.98% since Daniel S. Goldman sold on July 12, 2023, versus +72.17% for the S&P 500.
Performance since this trade
All Daniel S. Goldman HALO trades
Daniel S. Goldman & HALO trading FAQ
Is it legal for Daniel S. Goldman to trade Halozyme Therapeutics Inc (HALO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Halozyme Therapeutics Inc (HALO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell HALO?
Daniel S. Goldman disclosed a sale of $15,001 - $50,000 of Halozyme Therapeutics Inc (HALO) on July 12, 2023, according to public STOCK Act filings.
How has HALO performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold HALO on July 12, 2023, the stock is up +123.98%, versus +72.17% for the S&P 500 over the same period, an outperformance of +51.82%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional HALO trades?
Quantellect tracks every disclosed congressional trade in Halozyme Therapeutics Inc (HALO) on the Halozyme Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's HALO tradesAll congressional filings for Halozyme Therapeutics IncDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.